These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10593350)

  • 1. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis.
    Menghini VV; Savcenko V; Olson LJ; Tazelaar HD; Dec GW; Kao A; Cooper LT
    Mayo Clin Proc; 1999 Dec; 74(12):1221-6. PubMed ID: 10593350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of immunosuppression for giant cell myocarditis.
    Cooper LT; Hare JM; Tazelaar HD; Edwards WD; Starling RC; Deng MC; Menon S; Mullen GM; Jaski B; Bailey KR; Cunningham MW; Dec GW;
    Am J Cardiol; 2008 Dec; 102(11):1535-9. PubMed ID: 19026310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.
    Mason JW; O'Connell JB; Herskowitz A; Rose NR; McManus BM; Billingham ME; Moon TE
    N Engl J Med; 1995 Aug; 333(5):269-75. PubMed ID: 7596370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis.
    Desjardins V; Pelletier G; Leung TK; Waters D
    Can J Cardiol; 1992 Oct; 8(8):788-92. PubMed ID: 1422999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy.
    Pinderski LJ; Fonarow GC; Hamilton M; Fishbein MC; Marelli D; Moriguchi J; Cohen B; Kobashigawa JA
    J Heart Lung Transplant; 2002 Jul; 21(7):818-21. PubMed ID: 12100910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic and cytokine response to immunosuppression in giant-cell myocarditis.
    Levy NT; Olson LJ; Weyand C; Brack A; Tazelaar HD; Edwards WD; Hammill SC
    Ann Intern Med; 1998 Apr; 128(8):648-50. PubMed ID: 9537938
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathogenesis and treatment of myocarditis: the United States Myocarditis Treatment Trial.
    Mason JW
    J Card Fail; 1996 Dec; 2(4 Suppl):S173-7. PubMed ID: 8951576
    [No Abstract]   [Full Text] [Related]  

  • 8. Giant cell myocarditis responding to immunosuppressive therapy.
    Frustaci A; Chimenti C; Pieroni M; Gentiloni N
    Chest; 2000 Mar; 117(3):905-7. PubMed ID: 10713027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal recurrence of fulminant giant cell myocarditis and recovery after initialisation of an alternative immunosuppressive regime.
    Fluschnik N; Escher F; Blankenberg S; Westermann D
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive treatment in myocarditis.
    Salvi A; Di Lenarda A; Dreas L; Silvestri F; Camerini F
    Int J Cardiol; 1989 Mar; 22(3):329-38. PubMed ID: 2707913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.
    Wojnicz R; Nowalany-Kozielska E; Wojciechowska C; Glanowska G; Wilczewski P; Niklewski T; Zembala M; Polonski L; Rozek MM; Wodniecki J
    Circulation; 2001 Jul; 104(1):39-45. PubMed ID: 11435335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the Myocarditis Treatment Trial for clinical practice.
    Brown CA; O'Connell JB
    Curr Opin Cardiol; 1996 May; 11(3):332-6. PubMed ID: 8835876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.
    Weitsman T; Weisz G; Keren A; Hasin T
    Clin Res Cardiol; 2016 Sep; 105(9):794-6. PubMed ID: 27091051
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of OKT3 for acute myocarditis in infants and children.
    Ahdoot J; Galindo A; Alejos JC; George B; Burch C; Marelli D; Sadeghi A; Laks H
    J Heart Lung Transplant; 2000 Nov; 19(11):1118-21. PubMed ID: 11077231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.
    Escher F; Kühl U; Lassner D; Poller W; Westermann D; Pieske B; Tschöpe C; Schultheiss HP
    Clin Res Cardiol; 2016 Dec; 105(12):1011-1020. PubMed ID: 27312326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.
    Kleinert S; Weintraub RG; Wilkinson JL; Chow CW
    J Heart Lung Transplant; 1997 Dec; 16(12):1248-54. PubMed ID: 9436137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal Infiltrate of Unknown Cause.
    McKay KM; Sobrin L
    JAMA Ophthalmol; 2019 Feb; 137(2):222-223. PubMed ID: 30543336
    [No Abstract]   [Full Text] [Related]  

  • 18. Giant cell myocarditis: diagnosis and treatment.
    Cooper LT
    Herz; 2000 May; 25(3):291-8. PubMed ID: 10904855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis.
    Suarez-Barrientos A; Wong J; Bell A; Lyster H; Karagiannis G; Banner NR
    Am J Cardiol; 2015 Aug; 116(3):447-51. PubMed ID: 26048854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.
    Frustaci A; Chimenti C; Calabrese F; Pieroni M; Thiene G; Maseri A
    Circulation; 2003 Feb; 107(6):857-63. PubMed ID: 12591756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.